[1] 金晶, 李镭, 李为民. 影响肺癌转移部位的临床因素分析[J].华西医学, 2018, 33(1): 41-46.
[2] Wang WJ,Tao Z, Gu W, et al.Variation of blood T Lymphocyte subgroups in patients with Non-small Cell Lung Cancer[J].Asian Pac J Cancer Prev,2013, 14(8): 4671-4673.
[3] Yuan I. Escitalopram oxalate inhibits proliferation and migration and induces apoptosis in nonsmall cell lung cancer cells[J].Oncol Lett,2018, 15(3):3376-3382.
[4] 李建华, 唐小万. XELOX 辅助化疗对老年结肠癌根治术后患者治疗效果、生存质量及免疫功能的影响[J].中国老年学杂志, 2018,38(3): 587-589.
[5] 巫志华. 非小细胞癌术后辅助顺铂和紫杉醇治疗的临床效果及对患者免疫功能和预后的影响[J].实用癌症杂志, 2018,33(1):72-74.
[6] 蒋雷,费鲜明,阮建胜.化疗对肺癌患者细胞免疫功能的影响[J].浙江实用医学, 2013, 18(6):439-442.
[7] Butts CA, Ding K, Seymour L, et al. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage ⅠB and Ⅱ non-small-cell lung cancer: updated survival analysis of JBR-10[J].Clin Oncol,2010, 28(1): 29-34.
[8] 张皓, 李晓林. 老年晚期结直肠癌病人化疗前后外周血 T 淋巴细胞亚群变化[J].实用老年医学,2017, 31(12): 1114-1116.
[9] 王飞.丙泊酚联合顺式阿曲库铵对老年结直肠癌患者围手术期外周血T淋巴细胞亚群的影响[J].实用癌症杂志,2017,32(3):408-410. |
2020, Vol. 37 
